calaspargase pegol-mknl 3,750 UNT in 5 mL Injection

RxCUI: 2121421
RxNorm name: calaspargase pegol-mknl 3,750 UNT in 5 mL Injection
Display name: calaspargase pegol-mknl 3,750 UNT in 5 mL Injection
Full name: calaspargase pegol-mknl 3,750 UNT in 5 mL Injection
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761102	Asparlas	calaspargase pegol-mknl	351(a)	Rx	2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
asparlas	CALASPARGASE PEGOL	Servier Pharmaceuticals LLC	6585bd0d-bd78-4341-9e87-0f7664821f05	2024-10-08	Warnings, Adverse reactions	Exact identifier rxcui: 2121421

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
6585bd0d-bd78-4341-9e87-0f7664821f05	calaspargase pegol-mknl 3,750 UNT in 5 mL Injection [PSN] · 5 ML calaspargase pegol-mknl 750 UNT/ML Injection [SCD] · calaspargase pegol-mknl 3,750 UNT per 5 ML Injection [SY] · calaspargase pegol-mknl 750 UNT/ML per 5 ML Injection [SY]	4	12	These highlights do not include all the information needed to use ASPARLAS safely and effectively. See full prescribing information for ASPARLAS. ASPARLAS ® (calaspargase pegol-mknl) injection, for intravenous use Initial U.S. Approval: 2018	20241008